The trend of the index was divided throughout the day. As of the close, the Shanghai index rose 1.22%, the Shenzhen Composite Index rose 1.27% and the gem index fell 0.02%. Coal, COVID-19 testing, Baijiu and real estate growth were among the top. Port shipping, tourism and logistics declined. Chongqing Zhifei Biological Products Co.Ltd(300122) fell 15%, leading the gem. Nearly 3200 stocks in the two cities rose, and 85 stocks rose by the daily limit, with a full day turnover of 870 billion yuan. As of the close, the Shanghai index rose 1.22%, the Shenzhen Composite Index rose 1.27% and the gem index fell 0.02%.
On the disk, the coal, real estate, Baijiu and semiconductors in the afternoon were stronger, and Pingdingshan Tianan Coal Mining Co.Ltd(601666) , Luzhou Laojiao Co.Ltd(000568) and Naura Technology Group Co.Ltd(002371) once touched the limit. Affected by the news related to HPV vaccine, Chongqing Zhifei Biological Products Co.Ltd(300122) fell 14%, leading the gem index, Beijing Wantai Biological Pharmacy Enterprise Co.Ltd(603392) fell more than 9%.
On the whole, whether the stock index can break through the market situation in the future still depends on the continuous rise of mainstream hot spots and the continuous entry of OTC funds. It is suggested to pay close attention to the changes of policy and capital. It is expected that the short-term slight consolidation of the Shanghai stock index is more likely, and the short-term downward trend of the gem is more likely. Investors are advised to wait and see for a while in the short term and continue to pay attention to the investment opportunities of undervalued blue chips in the middle line.
